GSK, Horlicks To Sell 5.69% Stake in Hindustan Unilever Worth USD 3.3 Bn

GSK, Horlicks To Sell 5.69% Stake in Hindustan Unilever Worth USD 3.3 Bn

  • 07-May-2020 12:00 PM
  • Journalist: Timothy Greene

On Thursday, GlaxoSmithKline Pte and Horlicks announced that they will sell 5.69% stake in Hindustan Unilever Limited (HUL) in a deal valued nearly at $3.3 billion. HUL is planning to sell its 13.4 crore equity shares at a decided price band of INR 1,850 to INR 1,950 on Thursday. HUL, the country’s largest fast-moving consumer goods (FMCG) company, witnessed a fall of 1.57% in its shares on Wednesday, 6th May 2020. The base price is 8 per cent lower than Wednesday’s closing price of INR 2,009.85. GlaxoSmithKline Consumer Healthcare India merged with HUL in December 2018 through a deal signed worth INR 31,700 crore to acquire Horlicks and Boost. While the deal was signed in December 2018, all the necessary approvals were made in April this year. Based on transfer of HUL’s 4.39 shares to each share of GSK CH India, GSK Plc. is holding 5.7% stake in HUL.

Related News

LG Chem to Cease Octanol Production at Naju Plant as Part of Strategic Realignment
  • 02-Dec-2024 1:20 PM
  • Journalist: Yage Kwon
Fatty Alcohol Prices Rise as Palm Oil Supply Tightens Asian market Faces Price
  • 13-Nov-2024 4:15 PM
  • Journalist: Marcel Proust
Global Fatty Alcohol Market Faces Pressure from Rising Palm Oil Costs
  • 01-Nov-2024 1:30 PM
  • Journalist: Thomas Jefferson
Rising Raw Material Costs Stages Bullish Outlook for Global Fatty Alcohol Prices
  • 30-Sep-2024 7:39 PM
  • Journalist: Yage Kwon